Deutsche Bank
IDXG

Deutsche Bank’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Deutsche Bank’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-70
Closed – – 5726
2017
Q4 		$0 Sell
70
-60
-46% -$725 ﹤0.01% 5240
2017
Q3 		$2K Buy
130
+70
+117% +$826 ﹤0.01% 4809
2017
Q2 		$0 Buy
60
+20
+50% +$392 ﹤0.01% 5223
2017
Q1 		$1K Buy
40
+24
+150% +$859 ﹤0.01% 4851
2016
Q4 		$0 Buy
+16
New +$510 ﹤0.01% 5165
2015
Q4 		– Sell
-27
Closed -$4K – 5483
2015
Q3 		$4K Buy
+27
New +$5.32K ﹤0.01% 5070
2015
Q2 		– Sell
-2
Closed – – 5531
2015
Q1 		$0 Sell
2
-296
-99% -$48.4K ﹤0.01% 6216
2014
Q4 		$53K Buy
+298
New +$53K ﹤0.01% 5097
2014
Q2 		– Hold
0
– – – 6163
2014
Q1 		– Sell
-50
Closed -$26K – 5877
2013
Q4 		$24K Buy
50
+2
+4% +$978 ﹤0.01% 4679
2013
Q3 		$23K Sell
48
-223
-82% -$107K ﹤0.01% 4878
2013
Q2 		$126K Buy
+271
New +$123K ﹤0.01% 4095

Other funds holding IDXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LCC
Lincoln Capital Corp East Greenwich, Rhode Island $308M AUM 24.88% 1-Year Est. Return

Deutsche Bank's IDXG Position: Q1 2018 in Review

Deutsche Bank sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2018, closing a stake of 70 shares.

Deutsche Bank first reported a position in IDXG in Q2 2013 and held it in 11 quarters. The position peaked at $126K in Q2 2013. 14 funds tracked by Wall St. Rank hold IDXG as of Q1 2018.

  • Deutsche Bank reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Deutsche Bank sold 70 Interpace Biosciences, Inc. Common Stock shares in Q1 2018.
  • Deutsche Bank first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
  • Deutsche Bank's Interpace Biosciences, Inc. Common Stock position peaked at $126K in Q2 2013.
  • 14 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.